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High glucose activates the p38 MAPK pathway in cultured
human peritoneal mesothelial cells
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activation. This activated p38 MAPK pathway may play a roleHigh glucose activates the p38 MAPK pathway in cultured
in the pathogenesis of peritoneal fibrosis.human peritoneal mesothelial cells.
Background. Peritoneal fibrosis is a serious complication in
long-term continuous ambulatory peritoneal dialysis (CAPD)
patients, but the underlying mechanism is not well understood. Continuous ambulatory peritoneal dialysis (CAPD)Since high glucose activates the p38 mitogen-activated protein
has been used as a long-term renal replacement therapykinase (MAPK) pathway in various kinds of cells, and because
for patients with end-stage renal disease. However, aftermesothelial cells are always exposed to high glucose dialysate,
we examined the activity and expression of p38 MAPK mem- long-term treatment with CAPD, peritoneal fibrosis has
bers in cultured human peritoneal mesothelial cells (HPMCs) been observed in some patients, resulting in membrane
under high glucose conditions. failure [1–3]. In vitro and in vivo studies have demon-
Methods. HPMCs were isolated from omentum and subcul-
strated that denudation of mesothelial cells from the peri-tured. After serum restriction, HPMCs were exposed to 5.6
toneum and excessive deposition of extracellular matrixmmol/L glucose (low glucose), 5.6 mmol/L glucose 34.5 mmol/L
mannitol (low glucosemannitol), or 40 mmol/L glucose (high (ECM) are the structural determinants of peritoneal fi-
glucose) for 3 minutes to 48 hours with or without SB203580. brosis [1, 4, 5]. High glucose in peritoneal dialysis solution
Reverse transcription-polymerase chain reaction (RT-PCR) has been implicated to be a major factor in the pathogene-
and Western blot were performed to determine mRNA and sis of peritoneal fibrosis. Prior studies have postulatedprotein expression, respectively.
that high glucose concentrations suppress the growth andResults. p38 MAPK and cyclic adenosine monophosphate
regeneration of mesothelial cells [6], enhance transform-(cAMP)-responsive element binding protein (CREB) activities
and mRNA expressions were significantly increased in HPMCs ing growth factor- (TGF-) gene expression [7–10], and
exposed to high glucose compared to low glucose or low stimulate fibronectin synthesis [9–11], all of which may
glucose  mannitol after 10 minutes and remain at higher contribute to peritoneal fibrosis, but the precise cellular
levels to 48 hours (P  0.05), but total p38 MAPK and CREB
mechanisms modulating the expression of cytokine andprotein expressions did not differ. MAPK kinase 3/6 (MKK3/6)
ECM are not fully understood.activity and mRNA expression were also higher in high glucose
Numerous studies have revealed that protein kinase Ccells after 3 minutes (P 0.05), and fibronectin mRNA expres-
sion was significantly increased in HPMCs exposed to high (PKC) is activated in diabetic conditions, in vivo and in
glucose after 2 hours (P  0.05). In contrast, high glucose vitro [12–14]. In addition, PKC was also activated in
significantly inhibited MAPK phosphatase-1 (MKP-1) protein human peritoneal mesothelial cells (HPMCs) exposed toand mRNA expression after 10 minutes (P  0.05). SB203580
high glucose, leading to increased TGF- and fibronectin(1 mol/L) pretreatment for 1 hour significantly reduced high
synthesis [10]. PKC propagates the physiologic responsesglucose–induced CREB activity and fibronectin mRNA expres-
sion by 89% and 75%, respectively (P  0.05). of receptor-ligand interactions via an array of down-
Conclusion. p38 MAPK activity was increased in HPMCs stream signals, such as mitogen-activated protein kinases
exposed to high glucose, in parallel with increased MKK3/6 (MAPKs). Ultimately, transmitted signals regulate the
activity and decreased MKP-1 expression, resulting in CREB
transcription of genes responsible for key cellular re-
sponses, such as proliferation, differentiation, and apo-
ptosis [15–20].Key words: peritoneal fibrosis, high glucose, mesothelial cells, p38
MAPK, fibronectin. The MAPK family includes the extracellular signal-
regulated kinase-1/2 (ERK-1/2) or p42/44 MAPK, stress-Received for publication June 6, 2002
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a pivotal role in growth factor–induced mitogenesis, dif- ized by inverted phase-contrast microscopy and by the
presence of vimentin and cytokeratin, and by the absenceferentiation, and cellular transformation [15, 16, 18].
JNK/SAPK and p38 MAPK represent two independent of desmin and human factor VIII, by immunofluores-
cence microscopy. All experiments were performed us-parallel MAPK pathways that are activated in response
to stress signals, such as proinflammatory cytokines [21], ing cells between the first and third passages.
To determine the effect of high glucose on the p38ultraviolet irradiation [22], osmolality changes [23], and
oxidants [24], leading to alterations in cell growth, prostan- MAPK pathway, subconfluent HPMCs were incubated
with medium containing 0.5% FBS for 48 hours to arrestoid production, and other forms of cellular dysfunction
[15–20]. and synchronize cell growth. After this time period, the
cells were treated with 0.5% FCS media containing 5.6Increased p38 MAPK activity has been demonstrated
in various cells cultured under high glucose conditions mmol/L d-glucose (low glucose), 5.6 mM d-glucose and
34.4 mmol/L mannitol (low glucose  mannitol), or 40[25–28]. Recently, we demonstrated that p38 MAPK
mRNA and activity are increased in diabetic glomeruli, mmol/L d-glucose (high glucose), and harvested after 3
minutes, 10 minutes, 0.5, 2, 24, and 48 hours. In studieswhich may contribute to ECM synthesis [29]. Since meso-
thelial cells, like mesangial cells, have the capacity to examining the role of the p38 MAPK pathway on fibro-
nectin synthesis, HPMCs were preincubated for an hourproduce a variety of matrix proteins, including fibronec-
tin [9–11], we surmised that p38 MAPK activity might with 1 mol/L SB203580, a p38 MAPK inhibitor, before
being stimulated with high glucose, and were harvestedbe increased in mesothelial cells by high glucose.
In this study, we examined the p38 MAPK pathway after 24 hours.
in HPMCs isolated from human omentum. In addition
Western blot analysisto p38 MAPK, we also studied (1) MAPK kinase 3/6
(MKK3/6), upstream activators of p38 MAPK [30, 31]; Western blot was performed as previously reported
[36]. HPMCs harvested from 100 mm plates were lysed in(2) cyclic andenosine monophosphate (cAMP)–responsive
element binding protein (CREB), a transcription factor sodium dodecyl sulfate (SDS) sample buffer (2% sodium
dodecyl sulfate, 10 mmol/L Tris-HCl, pH 6.8, 10% [vol/that is known to be under the control of p38 MAPK
[32, 33]; and (3) MAPK phosphatase-1 (MKP-1), a phos- vol] glycerol). Lysate was centrifuged at 10,000 g for 10
minutes at 4C and the supernatant was used for experi-phatase that dephosphorylates tyrosine and threonine
residues of p38 MAPK, resulting in the deactivation of ments. Protein concentrations were determined using a
Bio-Rad kit (Bio-Rad Laboratories, Inc., Hercules, CA,p38 MAPK [34]. The activities and the mRNA expres-
sions of these key signaling kinases were determined USA). Aliquots of 50 g protein were treated with Laem-
mli sample buffer, heated at 100C for 5 minutes, and elec-in HPMCs cultured under high glucose conditions. In
addition, we examined the relationship between the p38 trophoresed 50 g/lane in a 10% SDS-polyacrylamide
gel. Proteins were transferred to Hybond-ECL mem-MAPK pathway and fibronectin synthesis in HPMCs.
brane (Amersham Life Science, Inc., Arlington Heights,
IL, USA) using a Hoeffer semidry blotting apparatus
METHODS
(Hoeffer Instruments, San Francisco, CA, USA), and
HPMC culture the membrane was incubated in blocking buffer A (1 
PBS, 0.1% Tween-20, and 8% nonfat milk) for 1 hourHPMCs were isolated according to the method de-
scribed by Stylianou et al [35]. Briefly, a piece of human at room temperature, and then incubated overnight at
4C with a 1:1000 dilution of polyclonal antibody to p38omentum obtained from consenting patients undergoing
elective abdominal surgery was washed three times with MAPK, phospho-specific p38 MAPK, phospho-specific
MKK3/6, phospho-specific CREB (New England Bio-sterile phosphate-buffered saline (PBS) and incubated
in 0.05% trypsin-0.02% ethylenediaminetetraacetic acid labs, Inc., Beverly, MA, USA), or MKP-1 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA). The membrane(EDTA) solution for 20 minutes at 37C with continuous
shaking. After incubation, the suspension containing free was then washed once for 15 minutes and twice for 5
minutes in 1 X PBS with 0.1% Tween-20, and incubatedmesothelial cells was centrifuged at 100 g for 10 minutes
at 4C. The cell pellet was then washed once and sus- in buffer A with horseradish peroxidase–linked sheep
antimouse immunoglobulin (IgG) (Amersham Life Sci-pended in M199 medium supplemented with 10% fetal
bovine serum (FBS), 100 U/mL penicillin, 100 g/mL ence, Inc.) at a 1:1000 dilution. The washes were re-
peated, and the membrane developed with chemilumi-streptomycin, and 26 mmol/L NaHCO3, and seeded onto
culture dishes coated with rat type 1 collagen. The cells nescent agent (ECL; Amersham Life Science, Inc.).
were grown in the same medium at 37C in humidified
Total RNA extraction and reverse transcription5% CO2 in air, and the medium was changed 24 hours
after seeding, and then once every 3 days. HPMCs were Total RNA extraction and reverse transcription were
performed as previously described [36]. Eight hundredlidentified by their morphologic characteristics as visual-
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Table 1. Primer sequences and PCR conditions
Annealing
temperature No. of
Sequence (5 → 3) (C) cycles
GAPDH
Sense CCTGCACCACCAACTGCTTAGC 60 36
Antisense CCAGTGAGCTTCCCGTTCAGC
p38 MAPK
Sense TGAAATGACAGGCTACGTGG 62 40
Antisense CATCTATAAGGAGGTCCCTGA
MKK3
Sense GCTGTGTCTATCGTGCGGG 63 40
Antisense CCATCAGCTCCAGGTAGCTC
MKK6
Sense GGTGAAGGAAGATGACCTGG 63 42
Antisense GCCATGTATGGTTTGCAACC
MKP-1
Sense CCTCAAAGGAGGATACGAAGC 58 42
Antisense GCTCTTGTACTGGTAGTGACC
CREB
Sense GGGAAATTCTTTCAAGGAGGCC 63 38
Antisense CGACACTCTCGAGCTGCTTCC
Fibronectin
Sense CGAGAGTAAACCTGAAGCTG 58 38
Antisense CCTTGTGTCCTGATCGTTGC
Abbreviations are: GAPDH, glyceraldehyde-3-phosphate dehydrogenase; MAPK, mitogen-activating protein kinase; MMK3, MAPK kinase 3; MMK6, MAPK
kinase 6; MKP-1, MAPK phosphatase-1; CREB, cyclic adenosine monophosphate (cAMP)-responsive element-binding protein.
of RNA STAT-60 reagent (Tel-Test, Inc., Friendswood, used for glycerldehyde-3-phospahate dehydrogenase
TX, USA) were added to HPMCs grown on a 60 mm (GAPDH), p38 MAPK, and fibronectin mRNA, and
culture plate, the mixture was vortexed and stored for 20 ng for MKK3, MKK6, CREB, and MKP-1 mRNA.
5 minutes at room temperature, 400 l chloroform was PCR was performed using cDNA, Taq-Gold polymerase
then added, and the mixture shaken vigorously for 30 (1.5 U for GAPDH, p38 MAPK, and fibronectin; 2.5 U
seconds. After 3 minutes, the mixture was centrifuged for the remainder), sense and antisense primers (25 pmol
at 12,000g for 15 minutes at 4C and the upper aqueous for GAPDH, p38 MAPK, and fibronectin; 30 pmol for
phase containing the extracted RNA was transferred to the remainder), and 20 mol/L dNTP in a volume of
a new tube. The RNA was precipitated from the aqueous 50 L containing 1 X PCR buffer. The PCR conditions
phase by adding 400 L isopropanol and pelleted by used were as follows (Table 1): denaturation at 95C for
centrifuging at 12,000g for 30 minutes at 4C. The RNA 45 seconds, annealing at the corresponding temperature
precipitate was washed with 70% ice-cold ethanol, dried for 45 seconds, and extension at 72C for 2 minutes.
using a Speed Vac, and dissolved in diethyl pyrocarbo- Initial heating at 95C for 9 minutes and a final extension
nate (DEPC)-treated distilled water. RNA yield and at 72C for 7 minutes were performed for all PCRs. The
quality were assessed based on spectrophotometric mea- RT-PCR products were separated by electrophoresis,
sures at 260 and 280 wavelength.
band densities were measured using TINA image soft-
First strand cDNA was made by using a Boehringer
ware (Raytest, Straubenhardt, Germany), and the ratioMannheim cDNA synthesis kit (Boehringer Mannheim
of a specific gene to GAPDH was used for analysis.GmbH, Mannheim, Germany). Two g of HPMC RNA
For fibronectin mRNA expression, we used quantita-from each plate was reverse transcribed using 10 mol/L
tive competitive PCR. The competitor cDNA was usedrandom hexanucleotide primer, 1 mmol/L desoxynucleo-
as internal standard, and was designed to contain theside triphosphate (dNTP), 8 mmol/L MgCl2, 30 mmol/L
same base pair sequence as the target cDNA that wouldKCl, 50 mmol/L Tris-HCl, pH 8.5, 0.2 mmol/L dithiothrei-
allow efficient priming, but had a portion deleted so thatthol, 25 U RNAse inhibitor, and 40 U avian myelo-
the competitor PCR-generated fragment could be easilyblastoma virus (AMV) reverse transcriptase. The mixture
distinguished electrophoretically by size. The RT-PCRwas incubated at 30C for 10 minutes and 42C for 1 hour,
products were separated by electrophoresis, the bandfollowed by inactivation of enzyme at 99C for 5 minutes.
densities analyzed by TINA image software, the values
Polymerase chain reaction log transformed, and a log-linear regression analysis was
performed against the competitor concentration for eachThe primers used for the experiments are summarized
in Table 1. Ten ng HPMCs RNA per reaction tube was PCR tube. The quantity of cDNA in the test sample was
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Fig. 1. Western blot of total and phospho-
specific p38 mitogen-activated protein kinase
(MAPK) in human peritoneal mesothelial
cells (HPMCs) exposed to low glucose (LG)
and high gluclose (HG) for 3 minutes to 48
hours (representative of four blots). Phospho-
specific p38 MAPK protein expression (upper
panel) was significantly higher in HPMCs ex-
posed to high glucose than in those exposed
to low glucose at 10 minutes and sustained to
48 hours. Densitometric quantitation revealed
an average 1.9-fold increase in phospho-spe-
cific p38 MAPK expression in HPMCs under
high glucose conditions versus low glucose
conditions after 10 minutes (P  0.05). Total
p38 MAPK protein expression (lower panel)
was not different between the two groups.
defined as the amount at which the competitor and wild- mRNA in high glucose cells than in corresponding low
glucose cells after 10 minutes (P  0.05) (Fig. 2B).type optical density bands were equal.
Statistical analysis High glucose stimulates HPMC MKK3/6 activity and
mRNA expressionAll values are expressed as the mean standard error
of the mean (SEM). Statistical analysis was performed We then examined the activity and mRNA expression
of the upstream kinase activators of p38 MAPK, specifi-using the statistical package SPSS for Windows Version
7.51 (SPSS, Inc., Chicago, IL, USA). Results were analyzed cally, MKK3/6 [30, 31]. Phospho-specific MKK3/6 levels,
representing MKK3/6 activity, were significantly higherusing Student t test or analysis of variance (ANOVA)
for multiple comparisons. in HPMCs incubated in high glucose than in low glucose
at 3 minutes and remained at a higher level throughout
the study period (2.2-fold on average, P  0.05) (Fig.
RESULTS
3). The increase in phospho-specific MKK3/6 levels oc-
High glucose stimulates HPMC p38 MAPK activity curred earlier than that in phospho-specific p38 MAPK
and mRNA expression level, suggesting that MKK3/6 activation in HPMCs by
high glucose presumably led to p38 MAPK activation.We first performed a time-course study wherein we
simultaneously examined the activity, protein and mRNA There was no difference in total MKK3 protein expres-
sion between low glucose and high glucose cells (Fig. 3).expression of p38 MAPK in HPMCs cultured under high
glucose conditions. The activity of p38 MAPK, assessed MKK3 and MKK6 mRNA levels were also signifi-
cantly higher in HPMCs exposed to high glucose than inby phospho-specific p38 MAPK levels, was found to be
increased in HPMCs by high glucose at 10 minutes, and those exposed to low glucose (Fig. 4), and this remained
significant even after correcting for GAPDH mRNAthis was maintained at a higher level to 48 hours. There
was a significant increase in p38 MAPK activity in high levels (data not shown).
glucose cells compared to low glucose cells at all the
High glucose stimulates HPMC CREB activity andindicated times after 10 minutes (1.9-fold on average,
mRNA expressionP  0.05). Total p38 MAPK protein expression was not
different between the two groups (Fig. 1). Low glucose In order to determine whether the activation of the
p38 MAPK pathway could induce a parallel increase inmannitol had no effect on either the activity or total
protein expression of p38 MAPK (data not shown). the activity of a p38 MAPK target transcription factor,
we examined the activity and the mRNA expression ofEqual protein loading was confirmed by Coomassie Blue
staining of the gel. CREB, due to its role in fibronectin transcription [37, 38],
and immunoblotted cellular protein lysates using an anti-p38 MAPK mRNA expression was also higher in
HPMCs exposed to high glucose than in those exposed body to phospho-specific (activated) CREB. The repre-
sentative blot in Figure 5 shows that CREB activity wasto low glucose at all the indicated times after 10 minutes
(Fig. 2A). Low glucose  mannitol did not affect p38 significantly increased in high glucose cells relative to
low glucose cells at all the indicated times after 10 min-MAPK mRNA expression (data not shown). In contrast,
GAPDH mRNA levels did not differ. After correcting utes (2.3-fold on average, P  0.05). This trend was
similar to that of phospho-specific p38 MAPK, as shownfor GAPDH mRNA in each sample, there remained a
significantly higher level (average 2.2-fold) of p38 MAPK in Figure 1. Total CREB protein expression in high glu-
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Fig. 2. High glucose stimulates p38 mitogen-
activated protein kinase (MAPKP mRNA ex-
pression in human peritoneal mesothelial cells
(HPMCs). (A ) A representative p38 MAPK
reverse transcription-polymerase chain reac-
tion (RT-PCR) electrophoresis of high glu-
cose (HG) and low glucose (LG) cells at 3,
10, and 30 minutes, and 2, 24, and 48 hours
(N	 4). Compared to low glucose, p38 MAPK
mRNA expression was significantly increased
in high glucose cells at all the indicated times
after 10 minutes. (B ) There was a significant
increment in p38 MAPK/glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) mRNA
in HPMCs exposed to high glucose ( ) than
those exposed to low glucose () after 10
minutes. *P  0.05 vs. low glucose.
Fig. 3. Western blot of phospho-specific mi-
togen-activated protein kinase (MAPK) ki-
nase 3/6 (MKK3/6) in human peritoneal meso-
theial cells (HPMCs) exposed to low glucose
(LG) and high glucose (HG) for 3 minutes to
48 hours (representative of four blots). Phos-
pho-specific MKK3/6 protein expression was
significantly higher in HPMCs exposed to high
glucose than in those exposed to low glucose
throughout the study period. Densitometric
quantitation revealed that there was an average
2.2-fold increase in phospho-specific MKK3/6
expression in high glucose cells compared with
low glucose cells (P  0.05). There was no
difference in total MKK3 protein expression
between low glucose and high glucose cells.
Fig. 4. High glucose stimulates mitogen-acti-
vated protein kinase (MAPK) kinase 3
(MKK3) and MKK6 mRNA expression in hu-
man peritoneal mesothelial cells (HPMCs).
A representative MKK3 and MKK6 reverse
transcription-polymerase chain reaction (RT-
PCR) electrophoresis of high glucose (HG)
and low glucose (LG) cells at 3, 10, and 30
minutes, and 2, 24, and 48 hours (N 	 4).
MKK3 and MKK6 mRNA expression was sig-
nificantly higher in HPMCs incubated in high
glucose than in those exposed to low glucose.
Average 2.1- and 1.7-fold increments in MKK3
and MKK6 mRNA expressions were observed
in high glucose versus low glucose cells, re-
spectively (P  0.05).
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Fig. 5. Western blot of phospho-specific cyclic
adenosine monophosphate (cAMP)-responsive
element-binding (CREB) protein in human
peritoneal mesothelial cells (HPMCs) exposed
to low glucose (LG) and high glucose (HG)
for 3 minutes to 48 hours (representative of
four blots). Phospho-specific CREB protein
expression was significantly higher in HPMCs
exposed to high glucose than in those exposed
to low glucose at 10 minutes, and sustained to
48 hours. Densitometric quantitation revealed
an average 2.3-fold increase in phospho-spe-
cific CREB expression in high glucose–cultured
HPMCs versus low glucose–cultured HPMCs
after 10 minutes (P 0.05). Total CREB pro-
tein expression in high glucose cells was not
different from that in low glucose cells.
Fig. 6. High glucose stimulates cyclic adeno-
sine monophosphate (cAMP)-responsive ele-
ment-binding (CREB) protein mRNA ex-
pression in human peritoneal mesothelial cells
(HPMCs). (A ) A representative CREB re-
verse transcription-polymerase chain reaction
(RT-PCR) electrophoresis of high glucose
(HG) and low glucose (LG) cells at 3, 10 and
30 minutes, and 2, 24, and 48 hours (N 	
4). Compared to low glucose, CREB mRNA
expression was significantly increased in high
glucose cells at all the indicated time points
after 10 minutes. (B ) A significant increment
in CREB/glyceraldehyde-3-phosphate dehy-
drogenase (GAPDH) mRNA was observed in
HPMCs exposed to high glucose ( ) as com-
pared to those exposed to low glucose ()
after 10 minutes. *P  0.05 vs. low glucose.
cose cells was not different from that in low glucose cells glucose and low glucose were 3.33  0.31 amol/ng RNA
and 1.54  0.31 amol/ng RNA, respectively (Fig. 7).(Fig. 5).
High glucose also stimulated CREB mRNA expres-
High glucose inhibits HPMC MKP-1 protein andsion in HPMCs. CREB mRNA expression, as well as
mRNA expressionCREB/GAPDH mRNA ratios, were significantly higher
in HPMCs incubated in high glucose than in low glucose MKP-1 is known to dephosphorylate the tyrosine and
threonine residues of p38 MAPK, which results in itsat all times after 10 minutes (Fig. 6).
deactivation [34]. We examined whether changes in
High glucose stimulates HPMC fibronectin MKP-1 caused by high glucose contributed to the activa-
mRNA expression tion of p38 MAPK in HPMCs. MKP-1 protein and
mRNA levels were significantly lower in high glucoseIn order to correlate our observations with evolving
peritoneal fibrosis, we examined the mRNA expressions cells than in low glucose cells at 10 minutes, and main-
tained at a lower level to 48 hours (Figs. 8 and 9). Hence,of fibronectin, an ECM protein that accumulates in fi-
brotic peritoneum [2, 4, 5]. Fibronectin mRNA levels increased p38 MAPK activity could be attributed at least
in part to a decrement in MKP-1 expression.were found to be significantly higher in high glucose cells
than in low glucose cells after 2 hours (P  0.05). At 24 These results demonstrate, for the first time, that both
an increase in MKK3/6 activity and a decrease in MKP-1hours, fibronectin mRNAs of HPMCs exposed to high
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Fig. 7. High glucose stimulates fibronectin
mRNA expression in human peritoneal meso-
thelial cells (HPMCs). (A) A representative
fibronectin competitive reverse transcription-
polymerase chain reaction (RT-PCR) electro-
phoresis of low glucose (LG) and high glucose
(HG) cells at 24 hours (N 	 4). Each lane
represents a competitive RT-PCR reaction
(38 cycles) with a fixed amount of fibronectin
wild-type cDNA (451 bp) from the equivalent
of 10 ng RNA and a variable amount of fibro-
nectin competitor cDNA (313 bp) as follows:
lane 1, 50 amol/L; lane 2, 10 amol/L; lane
3, 5 amol/L; lane 4, 1 amol/L, and lane
5, 0.5 amol/L. (B ) A significant increase in
fibronectin mRNA expression was observed
in high glucose–cultured ( ) HPMCs versus
low glucose-cultured () HPMCs after 2
hours. *P  0.05 vs. low glucose.
Fig. 8. Western blot of mitogen-activated pro-
tein kinase (MAPK) phosphatase (MKP-1) in
human peritoneal mesothelial cells (HPMCs)
exposed to low glucose (LG) and high glucose
(HG) for 3 minutes to 48 hours (representa-
tive of four blots). MKP-1 protein expression
was significantly lower in HPMCs exposed to
high glucose than in those exposed to low
glucose at all the indicated times after 10 min-
utes. Densitometric quantitation revealed that
there was an average 57% decrease in MKP-1
expression in HPMCs cultured under high glu-
cose conditions versus those cultured under
low glucose conditions after 10 minutes (P 
0.05).
expression induced by high glucose contribute to p38 DISCUSSION
MAPK activation in HPMCs. Peritoneal fibrosis is one of the most serious complica-
tions of long-term CAPD and leads to membrane failure
The p38 MAPK inhibitor SB203580 inhibits high [1–3]. It is characterized by a denudation of mesothelial
glucose–induced p38 MAPK and CREB activity and cells from the peritoneum and the deposition of ECM
fibronectin mRNA expression in HPMCs [1, 4, 5]. Mesothelial cells in vitro have the capacity to
We next examined whether fibronectin mRNA ex- produce a variety of matrix proteins, including collagen
pression in HPMCs was dependent on the p38 MAPK 
1(I) and 
1(III), laminin, and fibronectin [39, 40], and
pathway. SB203580, a synthetic p38 MAPK inhibitor, several studies have shown that high glucose concentra-
was found to inhibit high glucose–induced p38 MAPK tions enhance fibronectin gene expression in HPMCs
activity in a dose-dependent manner (Fig. 10A). Phos- [9–11]. However, the cellular mechanism of this process
pho-specific p38 MAPK was reduced by 84% with 1 is not fully understood. The current study demonstrates
mol/L SB203580 (Fig. 10A). At this concentration, it for the first time that p38 MAPK activity is increased
also reduced high glucose–induced CREB activity and in HPMCs under high glucose conditions and that the
fibronectin mRNA expression by 89% and 75%, respec- activation of p38 MAPK is associated with and is likely
tively (Figs. 10B, 11). to be due to decreased MKP-1 expression in addition to
These results show for the first time that high glucose increased MKK3/6 activity and its mRNA expression.
induces fibronectin mRNA expression in HPMCs partly PKC is activated in diabetic conditions, in vivo and in
vitro [12–14], and in HPMCs cultured under high glucoseunder the control of the p38 MAPK pathway.
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Fig. 9. High glucose inhibits mitogen-activated
protein kinase (MAPK) phosphatase (MKP-1)
mRNA expression in human peritoneal meso-
thelial cells (HPMCs). (A ) A representative
MKP-1 reverse transcription-polymerase chain
reaction (RT-PCR) electrophoresis of high
glucose (HG) and low glucose (LG) cells at
3, 10, and 30 minutes, and 2, 24, and 48 hour
(N	 4). Compared to low glucose cells, MKP-1
mRNA expression was significantly lower in
high glucose cells at 10 minutes, and remained at
a lower level to 48 hours. (B) A significant de-
crease in MKP-1/glyceraldehyde-3-phosphate
dehydrogenase (GAPDH) mRNA was ob-
served in HPMCs exposed to high glucose ( )
as compared to those exposed to low glucose
() after 10 minutes. *P  0.05 vs. low glu-
cose.
Fig. 11. The p38 mitogen-activated protein kinase (MAPK) inhibitor
SB203580 inhibits fibronectin mRNA expression in human peritoneal
mesothelial cells (HPMCs) exposed to high glucose (HG) for 24 hours.
Pretreatment with 1 mol/L SB203580 (SB) for 1 hour significantly
inhibited high glucose–induced fibronectin mRNA expression in
HPMCs by 75% (N 	 4). Low glucose (LG)  mannitol (M) had no
effect on fibronectin mRNA expression in HPMCs. *P  0.05 vs. low
gluclose; #P  0.05 vs. high glucose.
media [10], and it propagates the physiologic responses
of receptor-ligand interactions via an array of down-
Fig. 10. Western blot of phospho-specific p38 mitogen-activated pro-
stream signals, which includes the MAPKs. Recently, wetein kinase (MAPK) and phospho-specific cyclic adenosine monophos-
phate (cAMP)-responsive element-binding (CREB) protein in human demonstrated that p38 MAPK mRNA expression and
peritoneal mesothelial cells (HPMCs) with or without p38 MAPK inhib- activity were increased in glomeruli in the first 2 monthsitor for 24 hours (representative of five blots). (A ) The p38 MAPK
after diabetes induction, along with increased fibronectininhibitor, SB203580, inhibited high glucose (HG)–induced p38 MAPK
activity in a dose-dependent manner. Densitometric quantitation re- mRNA and protein expression [29]. Therefore, in this
vealed that the phospho-specific p38 MAPK level was reduced by 84% study, we focused on the p38 MAPK pathway ratherwith 1 mol/L SB203580 pretreatment for an hour. Total p38 MAPK
than other MAPKs to identify the effector pathways thatprotein expression did not change with SB203580. LG is low glucose.
(B ) Pretreatment with 1 mol/L SB203580 for 1 hour also significantly mediate peritoneal fibrosis.
reduced high glucose (HG)–induced CREB activity in HPMCs by 89% p38 MAPK is a member of the MAPK family and is(P  0.05). Low glucose (LG)  mannitol had no effect on p38 MAPK
or CREB activity. known as a “stress-activated kinase” along with JNK
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[16–18]. It is strongly activated by environmental stres- findings suggest that in addition to increased MKK3/6
activity, decreased MKP-1 expression in HPMCs by highsors [21, 23] and results in cellular growth, differentia-
tion, and apoptosis [19, 41]. Increased p38 MAPK pro- glucose may contribute to the sustained activation of p38
MAPK after 10 minutes.tein and the activation of p38 MAPK were observed and
characterized in aortas derived from 6-week-old diabetic Once p38 MAPK is activated, it phosphorylates sev-
eral transcription factors such as activating transcriptionrats [25], and we demonstrated that glomerular p38
MAPK mRNA and protein expression as well as activity factor-1 (ATF-1), ATF-2, AP-1, and CREB [21, 30, 32,
33, 47]. AP-1 (c-fos/c-jun) and CREB are members ofwere increased early in diabetic in rats [29]. Other in
vitro studies also demonstrated that short-term exposure a transcription factor family, which converts rapid and
transient signals into long-term changes in gene expres-to high glucose activated p38 MAPK in cultured rat
vascular smooth muscle cells [26], mesangial cells [27], sion by binding to the 12-O-tetradecanoylphorbol-13-
acetate (TPA) response element (TRE) and the cAMPand human endothelial cells [28]. In the present study,
we observed that high glucose, but not mannitol, in- response element (CRE), respectively. Since the fibro-
nectin promotor contains a CRE located 170 bp ofcreased p38 MAPK mRNA expression and activity in
HPMCs, suggesting that the activation of the p38 MAPK the fibronectin gene [48], activated CREB can bind the
CRE portion of the fibronectin gene, leading to fibro-pathway by high glucose was not due to changes in osmo-
lality. In contrast to our previous study [29], the increase nectin mRNA expression. Kreisberg, Radnik, and Dreis-
berg [37] observed that the activation of PKC by highin HPMC p38 MAPK mRNA expression was not closely
associated with a concomitant increment in total p38 glucose plus TGF- or phorbol 12-myristate 13 acetate
(PMA) induced the phosphorylation and activation ofMAPK protein. Although the reasons for this divergence
in protein levels are unclear, species or experimental CREB, which resulted in the stimulation of fibronectin
transcription in mesangial cells in vitro. A recent studydifferences (i.e., in vivo vs. in vitro), or the existence of
posttranscriptional change in HPMCs may contribute. by Singh et al [49] also demonstrated that hexosamine-
induced fibronectin synthesis in mesangial cells was asso-The activity of the MAPK family, including p38
MAPK, is determined by a dynamic balance between ciated with increased CREB phosphorylation and nu-
clear CREB activity. Furthermore, our recent studyphosphorylation and dephosphorylation, which results
from dual specific protein kinases (MAPK kinase, MKK, showed that glomerular CREB mRNA and activity were
increased in diabetic rats, which, in turn, may have con-or MEK), an upstream activator of MAPK, and a phos-
phatase, respectively [30, 31, 34]. Among the numerous tributed to the increased levels of fibronectin synthesis
observed [29]. We now report increased CREB mRNAMAPK kinases, MKK3 and MKK6 are known to catalyze
the phosphorylation of p38 MAPK specifically and MKK4/ and activity followed by increased fibronectin mRNA
levels in cultured HPMCs under high glucose concentra-SEK1 to mediate the activation of both p38 MAPK and
JNK [30, 31]. The present study demonstrates for the first tions, which is in agreement with the findings of previous
studies [29, 37, 49].time that the activities of MKK3 and MKK6 and their
mRNA expressions are increased in HPMCs under high The blockade of the p38 MAPK pathway by SB203580
inhibited high glucose–induced fibronectin mRNA ex-glucose conditions, which presumably results in the acti-
vation of p38 MAPK. These results are comparable to pression, which suggests that fibronectin mRNA expres-
sion in HPMCs is in part dependent on the MKK3/6-p38the findings of our recent study on diabetic glomeruli [29].
MKP-1 dephosphorylates and inactivates various mem- MAPK-CREB axis. TGF- is known to play an important
role in peritoneal fibrosis as it does in diabetic nephropa-bers of the MAPK family, including ERK, p38 MAPK,
and JNK [34, 42]. MPK-1 is principally regulated at the thy [50, 51]. TGF- has been detected in drained CAPD
effluent [52] and HPMCs are known to synthesize TGF-transcriptional level [43] as evidenced by its very low to
undetectable mRNA expression in quiescent cells and [53]. Moreover, its expression is enhanced under high
ambient glucose conditions [7, 9, 10] and TGF- stimu-its rapid induction by multiple signaling molecules and
by stress [34, 42, 44, 45]. Even though high glucose is lates the expression of type I and type III collagen mRNA
expression in HPMCs [54]. Hung et al [54] demonstratedknown to exert cellular stress, the effect of hyperglyce-
mia on MKP-1 expression remains controversial. High that the ERK pathway was activated by TGF- in HPMCs,
and that the blockade of ERK by PD98059 attenuatedglucose inhibited MKP-1 mRNA and protein expression
in vascular smooth cells [46], while stimulating it in mes- the increase in 
1(I) collagen mRNA expression induced
by TGF-. However, they did not evaluate the p38angial cells [27]. The reasons for the discrepant effects
of high glucose on MKP-1 are unclear, but may result MAPK pathway or fibronectin mRNA expression. A
recent study in human mesangial cells showed thatfrom differences in cell type, the duration of high glucose
exposure, or the glucose concentrations used in each of stretch activated p38 MAPK, which independently in-
duced TGF-1 and fibronectin, and, in turn, the incre-the experiments. In this study, high glucose inhibited
MKP-1 protein as well as its mRNA expression. These ment in TGF-1, contributed to maintaining late p38
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14. Ziyadeh FN, Fumo P, Rodenberger CH, et al: Role of proteinMAPK activation, which perpetuated fibronectin accu-
kinase C and cyclic AMP/protein kinase A in high glucose-stimu-
mulation [55]. These findings are consistent with our lated transcriptional activation of collagen alpha 1 (IV) in glomeru-
lar mesangial cells. J Diabetes Complications 9:255–261, 1995current observation, even though the stimuli used were
15. Cobb MH, Robbins DJ, Boulton TG: ERKs, extracellular signal-different.
regulated MAP-2 kinases. Curr Opin Cell Biol 3:1025–1032, 1991
16. Davis RJ: The mitogen-activated protein kinase signal transduc-
tion pathway. J Biol Chem 268:14553–14556, 1993
CONCLUSION 17. Kyriakis JM, Banerjee P, Nikolakaki E, et al: The stress-activated
protein kinase subfamily of c-Jun kinases. Nature 369:156–160,p38 MAPK activity was increased in HPMCs under
1994
high glucose conditions, and this increase was associated 18. Seger R, Krebs EG: The MAPK signaling cascade. FASEB J
9:726–735, 1995with a increment in MKK3 and MKK6 activity and mRNA
19. Xia Z, Dickens M, Raingeaud J, et al: Opposing effects of ERKexpression. Furthermore, high glucose stimulated CREB
and JNK-p38 MAP kinases on apoptosis. Science 270:1326–1330,
activity and fibronectin mRNA expression partly via the 1995
20. Kramer RM, Roberts EF, Um SL, et al: p38 mitogen-activatedp38 MAPK pathway. Taken together, our findings sug-
protein kinase phosphorylates cytosolic phospholipase A2 (cPLA2)gest that the activation of the p38 MAPK signaling path-
in thrombin-stimulated platelets. J Biol Chem 271:27723–27729,
way in HPMCs by high glucose may contribute to the 1996
21. Raingeaud J, Gupta S, Rogers JS, et al: Pro-inflammatory cyto-pathogenesis of peritoneal fibrosis.
kines and environmental stress cause p38 mitogen-activated pro-
tein kinase activation by dual phosphorylation on tyrosine and
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